MedPath
HSA Approval

FONGTIT 600 CAPSULE

SIN03369P

FONGTIT 600 CAPSULE

FONGTIT 600 CAPSULE

June 17, 1989

HUA TAI TRADING COMPANY PTE. LTD.

HUA TAI TRADING COMPANY PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantHUA TAI TRADING COMPANY PTE. LTD.
Licence HolderHUA TAI TRADING COMPANY PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N02BA55

salicylamide, combinations excl. psycholeptics

Manufacturer Information

HUA TAI TRADING COMPANY PTE. LTD.

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

SALICYLAMIDE

250 mg

Salicylamide

CAFFEINE (ANHYDROUS)

30 mg

Caffeine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FONGTIT 600 CAPSULE - HSA Approval | MedPath